Plasma Fractionation Market – Greater Growth Rate during forecast

According to the latest study on “Plasma Fractionation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, and End User,” the market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021–2028. The report highlights the trends prevailing in the global plasma fractionation market, and drivers and deterrents pertaining to the market growth.

The process of separating various components of blood plasma is known as plasma fractionation. The separated components are used to create a variety of therapeutic plasma products that can be used to treat a variety of medical conditions. Immunoglobulin, coagulation factors, albumins, and inhibitors are just a few of the plasma products commonly used.

Get Sample Copy of Report PDF:

The plasma fractionation market is segmented on the bases of product, application, and end user. Based on product, the market is subsegmented into immunoglobulin, albumin, coagulation factor concentrates, protease inhibitors, and others. The plasma fractionation market, by application, is further segmented into neurology, immunology, hematology, critical care, pulmonology, and others. The market, based on end user, is subsegmented into hospitals and clinics, clinical research laboratories, and academic institutes.

In terms of geography, the medical aesthetics market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and Rest of MEA), and South and Central America (Brazil, Argentina, and Rest of SCAM).

Buy Now:

Bio Products Laboratory LTD, CSL Limited, Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Grifols S.A, Kedrion, SK Plasma, Plasmagen Biosciences PVT. LTD, and Octapharma AG are among the prominent players operating in the plasma fractionation market. These companies are focusing on partnerships, product launches, collaborations, and other business strategies to sustain their position in the market. For instance, in May 2021, Liminal BioSciences entered into an agreement with Kedrion to divest its plasma collection and plasma-derived therapeutics business.

Browse More Related Reports by the insight partners:

Durable Medical Equipment Market

Enteral Feeding Devices Market      

Fire Safety Equipment Market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi


Phone: +1-646-491-9876




Comments are closed